HIV and Aging: Double Stigma
February 5, 2024Older people living with HIV may experience intersectional stigma resulting from HIV and ageism. The current review summarizes the scientific literature and focuses on social isolation and lack of social support as key factors in experiencing HIV-related and aging-related stigma.
HIV Clinical, Comorbid, and Social Determinants of Health are Linked with Brain Aging
Findings indicate that comorbid and social determinants of health are associated with brain aging in people with HIV, alongside traditional HIV metrics such as viral load and CD4 cell count, suggesting the need for a broadened clinical perspective on healthy aging with HIV, with additional focus on comorbidities, lifestyle changes, and social factors.
Integrating Frailty and Functional Outcomes into Clinical Trials
Considerations of frailty and functional outcomes for better integration and representation of aging patients in clinical trials.
Inflamm-aging: Effects of Chronic Inflammation with HIV
Advances in Antiretroviral therapy (ART) allow people with HIV to live longer with fewer medications. Join us as Dr. Peter Hunt details the connection between chronic inflammation and HIV infection and discusses care considerations and emerging research.
National HIV/AIDS Aging Awareness Day 2022 Twitter Chat
October 21, 2022Read the transcript of our Twitter Chat on Aging with HIV at the hashtag #NHAADchat.
Infection with HIV can accelerate aging within the first two to three years of infection, study says
July 18, 2022Researchers with University of California, Los Angeles (UCLA) looked at blood samples from more than 200 men to compare those infected with HIV to a control group who did not have HIV, and scored them on five different measures of aging.
Monocytes in HIV and SIV Infection and Aging: Implications for Inflamm-Aging and Accelerated Aging
February 17, 2022With ART and the extended lifespan of PLWH, HIV comorbidities also include aging—most likely due to accelerated aging—as well as cardiovascular, neurocognitive disorders, lung and kidney disease, and malignancies. The broad evidence suggests that HIV with ART is associated with accentuated aging and that the age-related comorbidities occur earlier, due in part to chronic immune activation, co-infections, and possibly the effects of ART alone.
Addressing Health Disparities in HIV: Introduction to the Special Issue, JAIDS Journal of Acquired Immune Deficiency Syndromes: December 15, 2021
December 15, 2021This article is about how racial and ethnic minorities specifically in California are impacted by HIV/AIDS. It discusses how they tailored their programs to target low-income populations. This particular study was done to prevent further HIV infections in at-risk populations.
Barriers and opportunities for the mental health of LGBT older adults and older people living with HIV: A systematic literature review
November 16, 2021The study was conducted to review current literature regarding accessing mental health care among LGBT older adults and older PLWH. The results displayed a lack of provider competency in caring for LGBT patients, lower rates of insurance coverage, greater mental health burden, social and structural determinants of health, policy solutions, and technology and health literacy.
Multimorbidity in people with HIV using ART in the US: Projections to 2030
November 9, 2021Researchers forecast a “silver tsunami” in multimorbidity, polypharmacy, and healthcare costs in US residents with HIV.
Methamphetamine and cardiac disease among people with HIV infection
November 1, 2021This study evaluates the association between methamphetamine use and cardiac disease among PWH. The study displayed no association between methamphetamine abuse/dependence and a diagnosis of myocardial infarction or heart failure was found among PWH.
A Malawian Perspective on Aging and HIV/AIDS
September 18, 2021Although we live in an aging population, attention is far from focused on those 50 or older when it comes to HIV/AIDS in Malawi. HealthHIV Fellow Delroy White recently found himself asking, “What happens to older people when most medical interventions are directed towards younger populations?”
